507 related items for PubMed ID: 18088394
1. Long-term treatment of familial male-limited precocious puberty (testotoxicosis) with cyproterone acetate or ketoconazole.
Almeida MQ, Brito VN, Lins TS, Guerra-Junior G, de Castro M, Antonini SR, Arnhold IJ, Mendonca BB, Latronico AC.
Clin Endocrinol (Oxf); 2008 Jul; 69(1):93-8. PubMed ID: 18088394
[Abstract] [Full Text] [Related]
2. Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty.
Paterson WF, McNeill E, Young D, Donaldson MD.
Clin Endocrinol (Oxf); 2004 Nov; 61(5):626-34. PubMed ID: 15521967
[Abstract] [Full Text] [Related]
3. Effectiveness of anastrozole and cyproterone acetate in two brothers with familial male precocious puberty.
Eyssette-Guerreau S, Pinto G, Sultan A, Le Merrer M, Sultan C, Polak M.
J Pediatr Endocrinol Metab; 2008 Oct; 21(10):995-1002. PubMed ID: 19209621
[Abstract] [Full Text] [Related]
4. Long-term outcome of male-limited gonadotropin-independent precocious puberty.
Bertelloni S, Baroncelli GI, Lala R, Cappa M, Matarazzo P, De Sanctis C, Saggese G.
Horm Res; 1997 Oct; 48(5):235-9. PubMed ID: 9362394
[Abstract] [Full Text] [Related]
5. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate).
Juul A, Scheike T, Nielsen CT, Krabbe S, Müller J, Skakkebaek NE.
J Clin Endocrinol Metab; 1995 Oct; 80(10):3059-67. PubMed ID: 7559897
[Abstract] [Full Text] [Related]
6. Adult height after ketoconazole treatment in patients with familial male-limited precocious puberty.
Soriano-Guillén L, Lahlou N, Chauvet G, Roger M, Chaussain JL, Carel JC.
J Clin Endocrinol Metab; 2005 Jan; 90(1):147-51. PubMed ID: 15522928
[Abstract] [Full Text] [Related]
7. Testotoxicosis: current viewpoint.
Reiter EO, Norjavaara E.
Pediatr Endocrinol Rev; 2005 Dec; 3(2):77-86. PubMed ID: 16361981
[Abstract] [Full Text] [Related]
8. Long-acting GnRH analogue triptorelin therapy in central isosexual precocious puberty.
Bajpai A, Sharma J, Kabra M, Gupta AK, Menon PS.
Indian Pediatr; 2002 Jul; 39(7):633-9. PubMed ID: 12147888
[Abstract] [Full Text] [Related]
9. Growth and precocious puberty.
Chaussain JL, Couprie C, Lacaille F, Simon D, Job JC.
Acta Paediatr Scand Suppl; 1988 Jul; 347():38-43. PubMed ID: 2978196
[Abstract] [Full Text] [Related]
10. [Precocious puberty in boys. Study of a series of 34 cases].
Blanco-Garcia M, Job JC, Chaussain JL, Canlorbe P.
Arch Fr Pediatr; 1983 Oct; 40(8):637-42. PubMed ID: 6418108
[Abstract] [Full Text] [Related]
11. [Cyproterone acetate in the treatment of girls with central precocious puberty].
Snajderová M, Lebl J, Zemková D, Zounarová M, Dvorák P, Kolousková S.
Cesk Pediatr; 1991 Mar; 46(3):146-8. PubMed ID: 1832589
[Abstract] [Full Text] [Related]
12. Combined treatment with ketoconazole and cyproterone acetate in a boy with McCune-Albright syndrome and peripheral precocious puberty.
Messina MF, Arrigo T, Wasniewska M, Lombardo F, Crisafulli G, Salzano G, De Luca F.
J Endocrinol Invest; 2008 Sep; 31(9):839-40. PubMed ID: 18997496
[No Abstract] [Full Text] [Related]
13. Pubertal development in girls with sexual precocity after discontinuation of treatment with cyproterone acetate.
Kauli R, Laron Z.
Helv Paediatr Acta; 1980 May; 35(2):149-54. PubMed ID: 6450194
[Abstract] [Full Text] [Related]
14. Combination therapy with GH and cyproterone acetate does not improve final height in boys with non-GH-deficient short stature.
Kawai M, Momoi T, Yorifuji T, Muroi J, Yamanaka C, Sasaki H, Furusho K.
Clin Endocrinol (Oxf); 1998 Jan; 48(1):53-7. PubMed ID: 9509068
[Abstract] [Full Text] [Related]
15. Precocious puberty and statural growth.
Carel JC, Lahlou N, Roger M, Chaussain JL.
Hum Reprod Update; 2004 Jan; 10(2):135-47. PubMed ID: 15073143
[Abstract] [Full Text] [Related]
16. Initial growth deceleration during GnRH analogue therapy for precocious puberty.
Mouat F, Hofman PL, Jefferies C, Gunn AJ, Cutfield WS.
Clin Endocrinol (Oxf); 2009 May; 70(5):751-6. PubMed ID: 19178517
[Abstract] [Full Text] [Related]
17. [Precocious puberty associated with Von Recklinghausen's disease. Developmental follow-up under cyproterone acetate treatment].
Oyarzábal M, Puente M, Mayorga R, Olivera JE, Nadal I.
An Esp Pediatr; 1983 Jan; 18(1):55-61. PubMed ID: 6223550
[Abstract] [Full Text] [Related]
18. Testotoxicosis proved by immunohistochemical analysis and successfully treated with cyproterone acetate.
Itoh K, Nakada T, Kubota Y, Suzuki H, Ishigooka M, Izumi T.
Urol Int; 1996 Jan; 57(3):199-202. PubMed ID: 8912454
[Abstract] [Full Text] [Related]
19. [Study on cases of precocious puberty].
Nanbu A, Kumamoto Y, Takagi Y, Maruta H.
Hinyokika Kiyo; 1989 Oct; 35(10):1715-20. PubMed ID: 2532862
[Abstract] [Full Text] [Related]
20. Adult height following a combined treatment of ketoconazole - cyproterone acetate - leuprolide depot in a boy with atypical McCune-Albright syndrome.
Messina MF, Aversa T, de Sanctis L, Wasniewska M, Valenzise M, Pajno GB, De Luca F, Lombardo F.
Hormones (Athens); 2015 Oct; 14(2):286-92. PubMed ID: 25402389
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
